Pediatric Vaccine Global Market Report 2025

Description

Pediatric vaccines are medicinal formulations primarily administered to children to safeguard them against severe and often life-threatening diseases. These vaccines prepare a child's body to combat diseases more effectively by enhancing its natural defense mechanisms.

The primary classifications of pediatric vaccines are monovalent and multivalent. A monovalent vaccine comprises a single antigen strain. Various technologies, including live attenuated, inactivated, toxoid, conjugate, and others, are employed to confer immunity against infectious diseases, allergies, and cancer.

The pediatric vaccine market research report is one of a series of new reports from The Business Research Company that provides pediatric vaccine market statistics, including pediatric vaccines industry global market size, regional shares, competitors with a pediatric vaccine market share, detailed pediatric vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric vaccine industry. This pediatric vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pediatric vaccine market size has grown rapidly in recent years. It will grow from $45.9 billion in 2024 to $51.56 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, immunization policies to eradicate endemic diseases, increased funding for vaccine development.

The pediatric vaccine market size is expected to see rapid growth in the next few years. It will grow to $85.3 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing cases of invasive cervical cancer, strong late-stage pipeline and new drug approvals, increasing prevalence of infectious diseases. Major trends in the forecast period include developing combination vaccines to meet market demand, consider investing R&D activities for the development of effective vaccines, focusing on developing live attenuated vaccines, utilizing new immune engineering and advance delivery systems and implementing artificial intelligence (AI) in vaccine development to simplify the process and make manufacturing easy.

The escalating prevalence of chronic diseases, including tuberculosis, diphtheria, and pneumonia, among individuals aged 15 years and below is set to contribute to the expansion of the pediatric vaccines market. The risk of severe disease outcomes and complications from infectious diseases is on the rise among children and adolescents with chronic conditions. As of March 2022, as reported by the Australian Bureau of Statistics, approximately half of the overall population (46.6% or 11.6 million) had at least one chronic condition. This heightened prevalence of chronic diseases in children increases the demand for immunization against these conditions, thereby propelling the growth of the pediatric vaccine market.

The increasing incidence of pediatric diseases is anticipated to drive the growth of the pediatric vaccine market in the foreseeable future. Pediatric diseases encompass a range of disorders affecting children from infancy to puberty, varying in severity and chronicity. Vaccinations for pediatric diseases are crucial for preventing and managing a diverse spectrum of pediatric disorders. Administered to newborns and children, these vaccines offer protection against numerous infectious illnesses. For example, in April 2023, data from Asthma + Lung UK revealed a 149% increase in hospital stays for children with asthma in England and Wales between 2021 and 2022. The number of children hospitalized with asthma symptoms during 2020 and 2021 was 19,506, compared to 7,850 in the previous two years. Consequently, the growing prevalence of pediatric diseases is a key driver for the pediatric vaccine market.

The demand for innovative vaccines is consistently increasing to provide enhanced immunization against challenging infectious diseases (e.g., tuberculosis, HIV/AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development involve structural immunogenic design, gene-based vaccine platforms, and the formulation of effective adjuvant recombinant antigens. In response to the growing demand for novel vaccines, pediatric vaccine manufacturers and developers are continuously seeking innovation in vaccine design and manufacturing technologies. For example, in April 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the US FDA approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants.

Major companies in the pediatric vaccine market are prioritizing product approvals to better cater to the needs of their existing consumers. ABRYSVO is an FDA-approved vaccine for use in pregnant women, aiming to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in children up to 6 months of age. For instance, in August 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the US FDA approval of Pfizer's ABRYSVO vaccine for the prevention of Respiratory Syncytial Virus (RSV) in infants through active immunization of pregnant women at 32-36 weeks gestational age. This marks the first and only maternal vaccination approved in the United States to help protect newborns against lower respiratory tract illness (LRTD) and severe LRTD caused by RSV from birth to six months of age.

Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos-Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pediatric vaccine market consists of sales of BCG vaccines, hepatitis B vaccines, pentavalent vaccines, and rotavirus vaccines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer
Subsegments:
1) By Monovalent: Single Antigen Vaccines; Specific Disease Vaccines
2) By Multivalent: Combination Vaccines; Polyvalent Vaccines
Companies Mentioned: Merck & Co. Inc.; Serum Institute of India Pvt. Ltd.; Sanofi SA; Pfizer Inc.; AstraZeneca
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25857

1. Executive Summary

2. Pediatric Vaccine Market Characteristics

3. Pediatric Vaccine Market Trends And Strategies

4. Pediatric Vaccine Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pediatric Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Pediatric Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pediatric Vaccine Market Growth Rate Analysis
5.4. Global Pediatric Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pediatric Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pediatric Vaccine Total Addressable Market (TAM)

6. Pediatric Vaccine Market Segmentation

6.1. Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monovalent
Multivalent
6.2. Global Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated
Inactivated
Toxoid
Conjugate
Other Technologies
6.3. Global Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Disease
Allergy
Cancer
6.4. Global Pediatric Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Antigen Vaccines
Specific Disease Vaccines
6.5. Global Pediatric Vaccine Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combination Vaccines
Polyvalent Vaccines

7. Pediatric Vaccine Market Regional And Country Analysis

7.1. Global Pediatric Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pediatric Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Vaccine Market

8.1. Asia-Pacific Pediatric Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Vaccine Market

9.1. China Pediatric Vaccine Market Overview
9.2. China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Vaccine Market

10.1. India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Vaccine Market

11.1. Japan Pediatric Vaccine Market Overview
11.2. Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Vaccine Market

12.1. Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Vaccine Market

13.1. Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Vaccine Market

14.1. South Korea Pediatric Vaccine Market Overview
14.2. South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Vaccine Market

15.1. Western Europe Pediatric Vaccine Market Overview
15.2. Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Vaccine Market

16.1. UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Vaccine Market

17.1. Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Vaccine Market

18.1. France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Vaccine Market

19.1. Italy Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Vaccine Market

20.1. Spain Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Vaccine Market

21.1. Eastern Europe Pediatric Vaccine Market Overview
21.2. Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Vaccine Market

22.1. Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Vaccine Market

23.1. North America Pediatric Vaccine Market Overview
23.2. North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Vaccine Market

24.1. USA Pediatric Vaccine Market Overview
24.2. USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Vaccine Market

25.1. Canada Pediatric Vaccine Market Overview
25.2. Canada Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Vaccine Market

26.1. South America Pediatric Vaccine Market Overview
26.2. South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Vaccine Market

27.1. Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Vaccine Market

28.1. Middle East Pediatric Vaccine Market Overview
28.2. Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Vaccine Market

29.1. Africa Pediatric Vaccine Market Overview
29.2. Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pediatric Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pediatric Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Vaccine Market Competitive Landscape And Company Profiles

30.1. Pediatric Vaccine Market Competitive Landscape
30.2. Pediatric Vaccine Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Vaccine Market Other Major And Innovative Companies

31.1. GlaxoSmithKline PLC
31.2. Sinovac Biotech Ltd
31.3. Zydus Cadila
31.4. Indian Immunologicals Limited
31.5. Panacea Biotec
31.6. Takeda Pharmaceutical Company
31.7. Mitsubishi Tanabe Pharma Corporation
31.8. Daiichi Sankyo
31.9. CSL Limited
31.10. BIO-MED
31.11. Sun Pharmaceutical Industries Ltd
31.12. Sinopharm
31.13. Walvax biotechnology
31.14. Fosun Pharma
31.15. BioNTech

32. Global Pediatric Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Vaccine Market

34. Recent Developments In The Pediatric Vaccine Market

35. Pediatric Vaccine Market High Potential Countries, Segments and Strategies

35.1 Pediatric Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Pediatric Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Pediatric Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer